Pasithea Therapeutics Corp. (KTTAW) › Cost of RevenuePasithea Therapeutics Corp. (KTTAW) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2021: $17.3K2022: $113.2K$113.2K2021Cost of Revenue (USD)2022Fiscal YearCost of RevenueChange YoY2022$113.2K+555.3%2021$17.3K—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share